A case of severe pulmonary exacerbation in a young patient with cystic fibrosis in the era of CFTR modulators

Bibliographic Details
Title: A case of severe pulmonary exacerbation in a young patient with cystic fibrosis in the era of CFTR modulators
Authors: Chiara Lanfranchi, Carmela Rizza, Maria Chiara Russo, Irene Borzani, Salvatore Alessio Angileri, Erica Nazzari, Gianfranco Alicandro, Francesco Blasi, Valeria Daccò
Source: International Journal of Infectious Diseases, Vol 147, Iss , Pp 107190- (2024)
Publisher Information: Elsevier, 2024.
Publication Year: 2024
Collection: LCC:Infectious and parasitic diseases
Subject Terms: Bronchial artery embolization, Cystic fibrosis, CFTR modulators, Elexacaftor, Tezacaftor, Ivacaftor, Infectious and parasitic diseases, RC109-216
More Details: The introduction of CFTR modulator drugs like elexacaftor-tezacaftor-ivacaftor (ETI) has transformed the management of cystic fibrosis (CF), significantly improving symptoms, lung function, and quality of life, while reducing reliance on intravenous antibiotics. However, respiratory exacerbations in the CFTR modulators era remain poorly understood from both pathophysiological and clinical perspectives.We present the case of a 20-year-old Caucasian woman with CF (F508del/L1077P) who, after three years of ETI treatment, experienced a severe episode of hemoptysis, despite being almost asymptomatic in the weeks leading up to admission, requiring bronchial artery embolization. Following ETI treatment, auscultatory findings and FEV1 changes may be less significant, making the detection of respiratory exacerbation more challenging. This highlights the need for heightened vigilance in managing such cases and underscores the challenge of diagnosing and managing exacerbations in the era of modulators. Long term real-world studies are essential to comprehend the evolving course of the disease during ETI treatment.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1201-9712
Relation: http://www.sciencedirect.com/science/article/pii/S1201971224002613; https://doaj.org/toc/1201-9712
DOI: 10.1016/j.ijid.2024.107190
Access URL: https://doaj.org/article/16c9140f887340b1aa3f2a8d9ce36f1b
Accession Number: edsdoj.16c9140f887340b1aa3f2a8d9ce36f1b
Database: Directory of Open Access Journals
More Details
ISSN:12019712
DOI:10.1016/j.ijid.2024.107190
Published in:International Journal of Infectious Diseases
Language:English